Salona Global Medical Device Corporation
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Salona Global Medical Device Corporation (LNDZF) - Total Assets
Latest total assets as of September 2024: $35.13 Million USD
Based on the latest financial reports, Salona Global Medical Device Corporation (LNDZF) holds total assets worth $35.13 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Salona Global Medical Device Corporation - Total Assets Trend (2013–2024)
This chart illustrates how Salona Global Medical Device Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Salona Global Medical Device Corporation - Asset Composition Analysis
Current Asset Composition (February 2024)
Salona Global Medical Device Corporation's total assets of $35.13 Million consist of 43.5% current assets and 56.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.9% |
| Accounts Receivable | $9.84 Million | 20.4% |
| Inventory | $10.24 Million | 21.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.03 Million | 14.6% |
| Goodwill | $6.40 Million | 13.3% |
Asset Composition Trend (2013–2024)
This chart illustrates how Salona Global Medical Device Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Salona Global Medical Device Corporation's current assets represent 43.5% of total assets in 2024, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2024, down from 84.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 21.2% of total assets.
Salona Global Medical Device Corporation Competitors by Total Assets
Key competitors of Salona Global Medical Device Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Salona Global Medical Device Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Salona Global Medical Device Corporation generates 1.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Salona Global Medical Device Corporation is currently not profitable relative to its asset base.
Salona Global Medical Device Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.51 | 0.63 | 2.02 |
| Quick Ratio | 0.24 | 0.33 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-16.44 Million | $ -14.64 Million | $ 6.64 Million |
Salona Global Medical Device Corporation - Advanced Valuation Insights
This section examines the relationship between Salona Global Medical Device Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.70 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $48.26 Million |
| Market Capitalization | $215.78K USD |
Valuation Analysis
Below Book Valuation: The market values Salona Global Medical Device Corporation's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Salona Global Medical Device Corporation's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Salona Global Medical Device Corporation (2013–2024)
The table below shows the annual total assets of Salona Global Medical Device Corporation from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-02-29 | $48.26 Million | 0.00% |
| 2023-12-31 | $48.26 Million | -7.29% |
| 2023-02-28 | $52.05 Million | 0.00% |
| 2022-12-31 | $52.05 Million | +21.95% |
| 2022-02-28 | $42.68 Million | 0.00% |
| 2021-12-31 | $42.68 Million | +225.07% |
| 2021-02-28 | $13.13 Million | 0.00% |
| 2020-12-31 | $13.13 Million | +40.69% |
| 2019-12-31 | $9.33 Million | -19.69% |
| 2018-12-31 | $11.62 Million | +2.21% |
| 2017-12-31 | $11.37 Million | -50.30% |
| 2016-12-31 | $22.88 Million | -27.91% |
| 2015-12-31 | $31.74 Million | +223.18% |
| 2014-12-31 | $9.82 Million | +4168.85% |
| 2013-12-31 | $230.04K | -- |